Showing 9071-9080 of 21418 results for "".
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
https://reachmd.com/programs/cme/navigating-today-and-shaping-tomorrow-in-ism-personalized-strategies-with-current-and-emerging-kit-inhibitors/54388/Explore the latest clinical evidence on current and emerging KIT tyrosine kinase inhibitors in indolent systemic mastocytosis to optimize patient care.Conference Coverage at ICCBH 2026: A New Frontier in Achondroplasia—Clinical Insights From the PROPEL 3 Trial of Oral Infigratinib in Children
https://reachmd.com/clinical-practice/endocrinology/conference-coverage-at-iccbh-2026-a-new-frontier-in-achondroplasiaclinical-insights-from-the-propel-3-trial-of-oral-infigratinib-in-children/57926/Explore the efficacy, safety, and clinical implications of the PROPEL 3 trial evaluating oral infigratinib in children with achondroplasia.Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
https://reachmd.com/programs/cme/talking-through-treatment-patientclinician-dialogue-on-perioperative-immunotherapy-in-locally-advanced-hnscc/56431/Explore perioperative immunotherapy in locally advanced HNSCC through patient–clinician dialogue, clinical evidence, and multidisciplinary care.Inside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
https://reachmd.com/programs/cme/inside-the-cataracts-studio-advanced-fluidics-ergonomics-and-techniques-for-complex-cases-introducing-robotic-slacs/33177/Explore SLACS for cataract surgery, which features a robotic femtosecond laser integrated into the operating suite that can be utilized for complex cases.Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
https://reachmd.com/programs/cme/ibd-care-reimagined-personalized-proactive-and-target-driven-management/54174/Explore IBD treatment selection in this comprehensive program for community gastroenterologists, with topics including therapies, targets, and emerging data.Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
https://reachmd.com/programs/cme/improving-outcomes-and-addressing-racial-disparities-in-patients-with-hrher2-early-breast-cancer-a-case-based-learning-lab/16199/The goal of this educational activity is to improve clinical competence and practice skills among community and academic-based clinicians and interprofessional care teams treating and managing HR+/HER2- early breast cancer patients.Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
https://reachmd.com/programs/cme/chairpersons-perspective-evidence-informed-clinical-decision-making-in-her2-overexpressed-and-trop2-targeted-nsclc/39894/Study HER2 IHC testing, efficacy, and NCCN guidance supporting ADC sequencing for HER2-overexpressed NSCLC and TROP2-directed ADCs for EGFR-TKI–resistant NSCLC.Clinical Implications of Emerging Data on B7-H3–directed ADCs in the Future of ES-SCLC
https://reachmd.com/programs/cme/clinical-implications-of-emerging-data-on-b7-h3directed-adcs-in-the-future-of-es-sclc/39979/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 2
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-2/56870/In the second installment of a nine-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, review the study design, including patient selection, treatment regimens, and objective and subjective assessment methods used to evaluate outcomes.1